APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Function Testing Systems

Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.

Selected research

Market Outlook & Growth Opportunities

Global Pulmonary Function Testing Systems Market Outlook and Growth Opportunities 2026

Report ID 173920400421 December 2025198 pages

Choose your research edition.

Industry ResearchPulmonary Function Testing Systems Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Function Testing Systems Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pulmonary Function Testing Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Function Testing Systems Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Function Testing Systems Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.

Global Pulmonary Function Testing Systems main players are CareFusion(BD), Schiller, MGC Diagnostics, M&B, etc. Global top five manufacturers hold a share about 50%. Europe is the largest market, with a share about 30.

Read the full market overview

This report provides an overview of the global Pulmonary Function Testing Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pulmonary Function Testing Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pulmonary Function Testing Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pulmonary Function Testing Systems market size, projected growth trends, production technologies, key applications, and end-use industries.

Pulmonary Function Testing Systems Segment by Company

CareFusion(BD)

Schiller

CHEST

COSMED

nSpire Health

NDD

MGC Diagnostics

Minato

Ganshorn

AESRI

Morgan Scientific

M&B

Sikeda

RSDQ

Pulmonary Function Testing Systems Segment by Type

Portable PFT Systems

Complete PFT Systems

Pulmonary Function Testing Systems Segment by Application

Hospitals

Physical Examination Center

Physician Groups

Others

Pulmonary Function Testing Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pulmonary Function Testing Systems status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pulmonary Function Testing Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pulmonary Function Testing Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Pulmonary Function Testing Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Function Testing Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Function Testing Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Function Testing Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pulmonary Function Testing Systems market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pulmonary Function Testing Systems industry.

Chapter 3: Detailed analysis of Pulmonary Function Testing Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pulmonary Function Testing Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pulmonary Function Testing Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pulmonary Function Testing Systems Industry Trends Table 2. Pulmonary Function Testing Systems Industry Drivers Table 3. Pulmonary Function Testing Systems Industry Opportunities and Challenges Table 4. Pulmonary Function Testing Systems Industry Restraints Table 5. Global Pulmonary Function Testing Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pulmonary Function Testing Systems Revenue Share by Company (2021-2026) Table 7. Global Pulmonary Function Testing Systems Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Pulmonary Function Testing Systems Sales Volume Share by Company (2021-2026) Table 9. Global Pulmonary Function Testing Systems Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Pulmonary Function Testing Systems Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pulmonary Function Testing Systems Key Company Manufacturing Base & Headquarters Table 12. Global Pulmonary Function Testing Systems Company, Product Type & Application Table 13. Global Pulmonary Function Testing Systems Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pulmonary Function Testing Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Portable PFT Systems Table 18. Significant Companies of Complete PFT Systems Table 19. Global Pulmonary Function Testing Systems Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Pulmonary Function Testing Systems Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Pulmonary Function Testing Systems Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Pulmonary Function Testing Systems Sales Volume Share by Type (2021-2026) Table 23. Global Pulmonary Function Testing Systems Sales Volume Share by Type (2027-2032) Table 24. Global Pulmonary Function Testing Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pulmonary Function Testing Systems Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pulmonary Function Testing Systems Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pulmonary Function Testing Systems Sales Value Share by Type (2021-2026) Table 28. Global Pulmonary Function Testing Systems Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Physical Examination Center Table 31. Significant Companies of Physician Groups Table 32. Significant Companies of Others Table 33. Global Pulmonary Function Testing Systems Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Pulmonary Function Testing Systems Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Pulmonary Function Testing Systems Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Pulmonary Function Testing Systems Sales Volume Share by Application (2021-2026) Table 37. Global Pulmonary Function Testing Systems Sales Volume Share by Application (2027-2032) Table 38. Global Pulmonary Function Testing Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pulmonary Function Testing Systems Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pulmonary Function Testing Systems Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pulmonary Function Testing Systems Sales Value Share by Application (2021-2026) Table 42. Global Pulmonary Function Testing Systems Sales Value Share by Application (2027-2032) Table 43. Global Pulmonary Function Testing Systems Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Pulmonary Function Testing Systems Sales by Region (2021-2026) & (K Units) Table 45. Global Pulmonary Function Testing Systems Sales Market Share by Region (2021-2026) Table 46. Global Pulmonary Function Testing Systems Sales by Region (2027-2032) & (K Units) Table 47. Global Pulmonary Function Testing Systems Sales Market Share by Region (2027-2032) Table 48. Global Pulmonary Function Testing Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pulmonary Function Testing Systems Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pulmonary Function Testing Systems Sales Value Share by Region (2021-2026) Table 51. Global Pulmonary Function Testing Systems Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pulmonary Function Testing Systems Sales Value Share by Region (2027-2032) Table 53. Global Pulmonary Function Testing Systems Market Average Price (USD/Unit) by Region (2021-2026) Table 54. Global Pulmonary Function Testing Systems Market Average Price (USD/Unit) by Region (2027-2032) Table 55. Global Pulmonary Function Testing Systems Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Pulmonary Function Testing Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pulmonary Function Testing Systems Sales by Country (2021-2026) & (K Units) Table 58. Global Pulmonary Function Testing Systems Sales Market Share by Country (2021-2026) Table 59. Global Pulmonary Function Testing Systems Sales by Country (2027-2032) & (K Units) Table 60. Global Pulmonary Function Testing Systems Sales Market Share by Country (2027-2032) Table 61. Global Pulmonary Function Testing Systems Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pulmonary Function Testing Systems Sales Value Market Share by Country (2021-2026) Table 63. Global Pulmonary Function Testing Systems Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pulmonary Function Testing Systems Sales Value Market Share by Country (2027-2032) Table 65. CareFusion(BD) Company Information Table 66. CareFusion(BD) Business Overview Table 67. CareFusion(BD) Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 68. CareFusion(BD) Pulmonary Function Testing Systems Product Portfolio Table 69. CareFusion(BD) Recent Development Table 70. Schiller Company Information Table 71. Schiller Business Overview Table 72. Schiller Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. Schiller Pulmonary Function Testing Systems Product Portfolio Table 74. Schiller Recent Development Table 75. CHEST Company Information Table 76. CHEST Business Overview Table 77. CHEST Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. CHEST Pulmonary Function Testing Systems Product Portfolio Table 79. CHEST Recent Development Table 80. COSMED Company Information Table 81. COSMED Business Overview Table 82. COSMED Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. COSMED Pulmonary Function Testing Systems Product Portfolio Table 84. COSMED Recent Development Table 85. nSpire Health Company Information Table 86. nSpire Health Business Overview Table 87. nSpire Health Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. nSpire Health Pulmonary Function Testing Systems Product Portfolio Table 89. nSpire Health Recent Development Table 90. NDD Company Information Table 91. NDD Business Overview Table 92. NDD Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. NDD Pulmonary Function Testing Systems Product Portfolio Table 94. NDD Recent Development Table 95. MGC Diagnostics Company Information Table 96. MGC Diagnostics Business Overview Table 97. MGC Diagnostics Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. MGC Diagnostics Pulmonary Function Testing Systems Product Portfolio Table 99. MGC Diagnostics Recent Development Table 100. Minato Company Information Table 101. Minato Business Overview Table 102. Minato Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Minato Pulmonary Function Testing Systems Product Portfolio Table 104. Minato Recent Development Table 105. Ganshorn Company Information Table 106. Ganshorn Business Overview Table 107. Ganshorn Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Ganshorn Pulmonary Function Testing Systems Product Portfolio Table 109. Ganshorn Recent Development Table 110. AESRI Company Information Table 111. AESRI Business Overview Table 112. AESRI Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. AESRI Pulmonary Function Testing Systems Product Portfolio Table 114. AESRI Recent Development Table 115. Morgan Scientific Company Information Table 116. Morgan Scientific Business Overview Table 117. Morgan Scientific Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Morgan Scientific Pulmonary Function Testing Systems Product Portfolio Table 119. Morgan Scientific Recent Development Table 120. M&B Company Information Table 121. M&B Business Overview Table 122. M&B Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. M&B Pulmonary Function Testing Systems Product Portfolio Table 124. M&B Recent Development Table 125. Sikeda Company Information Table 126. Sikeda Business Overview Table 127. Sikeda Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. Sikeda Pulmonary Function Testing Systems Product Portfolio Table 129. Sikeda Recent Development Table 130. RSDQ Company Information Table 131. RSDQ Business Overview Table 132. RSDQ Pulmonary Function Testing Systems Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 133. RSDQ Pulmonary Function Testing Systems Product Portfolio Table 134. RSDQ Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Pulmonary Function Testing Systems Distributors List Table 138. Pulmonary Function Testing Systems Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Pulmonary Function Testing Systems Product Image Figure 2. Global Pulmonary Function Testing Systems Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Function Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pulmonary Function Testing Systems Sales (2021-2032) & (K Units) Figure 5. Global Pulmonary Function Testing Systems Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Pulmonary Function Testing Systems Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Portable PFT Systems Image Figure 10. Complete PFT Systems Image Figure 11. Global Pulmonary Function Testing Systems Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Pulmonary Function Testing Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pulmonary Function Testing Systems Sales Volume Share by Type (2021-2032) Figure 14. Global Pulmonary Function Testing Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pulmonary Function Testing Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pulmonary Function Testing Systems Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Physical Examination Center Image Figure 19. Physician Groups Image Figure 20. Others Image Figure 21. Global Pulmonary Function Testing Systems Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Pulmonary Function Testing Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pulmonary Function Testing Systems Sales Volume Share by Application (2021-2032) Figure 24. Global Pulmonary Function Testing Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pulmonary Function Testing Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pulmonary Function Testing Systems Sales Value Share by Application (2021-2032) Figure 27. Global Pulmonary Function Testing Systems Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Pulmonary Function Testing Systems Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pulmonary Function Testing Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pulmonary Function Testing Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pulmonary Function Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pulmonary Function Testing Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pulmonary Function Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pulmonary Function Testing Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pulmonary Function Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pulmonary Function Testing Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pulmonary Function Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pulmonary Function Testing Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pulmonary Function Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pulmonary Function Testing Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pulmonary Function Testing Systems Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pulmonary Function Testing Systems Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Portable PFT Systems
  • Complete PFT Systems
Applications
  • Hospitals
  • Physical Examination Center
  • Physician Groups
  • Others
Companies covered
  • CareFusion(BD)
  • Schiller
  • CHEST
  • COSMED
  • nSpire Health
  • NDD
  • MGC Diagnostics
  • Minato
  • Ganshorn
  • AESRI
  • Morgan Scientific
  • M&B
  • Sikeda
  • RSDQ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pulmonary Function Testing Systems Sales Value (2021-2032)
  4. 1.2.2 Global Pulmonary Function Testing Systems Sales Volume (2021-2032)
  5. 1.2.3 Global Pulmonary Function Testing Systems Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pulmonary Function Testing Systems Market Dynamics
  1. 2.1 Pulmonary Function Testing Systems Industry Trends
  2. 2.2 Pulmonary Function Testing Systems Industry Drivers
  3. 2.3 Pulmonary Function Testing Systems Industry Opportunities and Challenges
  4. 2.4 Pulmonary Function Testing Systems Industry Restraints
3 Pulmonary Function Testing Systems Market by Company
  1. 3.1 Global Pulmonary Function Testing Systems Company Revenue Ranking in 2025
  2. 3.2 Global Pulmonary Function Testing Systems Revenue by Company (2021-2026)
  3. 3.3 Global Pulmonary Function Testing Systems Sales Volume by Company (2021-2026)
  4. 3.4 Global Pulmonary Function Testing Systems Average Price by Company (2021-2026)
  5. 3.5 Global Pulmonary Function Testing Systems Company Ranking (2024-2026)
  6. 3.6 Global Pulmonary Function Testing Systems Company Manufacturing Base and Headquarters
  7. 3.7 Global Pulmonary Function Testing Systems Company Product Type and Application
  8. 3.8 Global Pulmonary Function Testing Systems Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pulmonary Function Testing Systems Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pulmonary Function Testing Systems Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pulmonary Function Testing Systems Market by Type
  1. 4.1 Pulmonary Function Testing Systems Type Introduction
  2. 4.1.1 Portable PFT Systems
  3. 4.1.2 Complete PFT Systems
  4. 4.2 Global Pulmonary Function Testing Systems Sales Volume by Type
  5. 4.2.1 Global Pulmonary Function Testing Systems Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pulmonary Function Testing Systems Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pulmonary Function Testing Systems Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pulmonary Function Testing Systems Sales Value by Type
  9. 4.3.1 Global Pulmonary Function Testing Systems Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pulmonary Function Testing Systems Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pulmonary Function Testing Systems Sales Value Share by Type (2021-2032)
5 Pulmonary Function Testing Systems Market by Application
  1. 5.1 Pulmonary Function Testing Systems Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Physical Examination Center
  4. 5.1.3 Physician Groups
  5. 5.1.4 Others
  6. 5.2 Global Pulmonary Function Testing Systems Sales Volume by Application
  7. 5.2.1 Global Pulmonary Function Testing Systems Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pulmonary Function Testing Systems Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Pulmonary Function Testing Systems Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Pulmonary Function Testing Systems Sales Value by Application
  11. 5.3.1 Global Pulmonary Function Testing Systems Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pulmonary Function Testing Systems Sales Value by Application (2021-2032)
  13. 5.3.3 Global Pulmonary Function Testing Systems Sales Value Share by Application (2021-2032)
6 Pulmonary Function Testing Systems Regional Sales and Value Analysis
  1. 6.1 Global Pulmonary Function Testing Systems Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pulmonary Function Testing Systems Sales by Region (2021-2032)
  3. 6.2.1 Global Pulmonary Function Testing Systems Sales by Region: 2021-2026
  4. 6.2.2 Global Pulmonary Function Testing Systems Sales by Region (2027-2032)
  5. 6.3 Global Pulmonary Function Testing Systems Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pulmonary Function Testing Systems Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pulmonary Function Testing Systems Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pulmonary Function Testing Systems Sales Value by Region (2027-2032)
  9. 6.5 Global Pulmonary Function Testing Systems Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pulmonary Function Testing Systems Sales Value (2021-2032)
  12. 6.6.2 North America Pulmonary Function Testing Systems Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pulmonary Function Testing Systems Sales Value (2021-2032)
  15. 6.7.2 Europe Pulmonary Function Testing Systems Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pulmonary Function Testing Systems Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pulmonary Function Testing Systems Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pulmonary Function Testing Systems Sales Value (2021-2032)
  21. 6.9.2 South America Pulmonary Function Testing Systems Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pulmonary Function Testing Systems Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pulmonary Function Testing Systems Sales Value Share by Country, 2025 VS 2032
7 Pulmonary Function Testing Systems Country-level Sales and Value Analysis
  1. 7.1 Global Pulmonary Function Testing Systems Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pulmonary Function Testing Systems Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pulmonary Function Testing Systems Sales by Country (2021-2032)
  4. 7.3.1 Global Pulmonary Function Testing Systems Sales by Country (2021-2026)
  5. 7.3.2 Global Pulmonary Function Testing Systems Sales by Country (2027-2032)
  6. 7.4 Global Pulmonary Function Testing Systems Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pulmonary Function Testing Systems Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pulmonary Function Testing Systems Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pulmonary Function Testing Systems Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pulmonary Function Testing Systems Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pulmonary Function Testing Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CareFusion(BD)
  2. 8.1.1 CareFusion(BD) Company Information
  3. 8.1.2 CareFusion(BD) Business Overview
  4. 8.1.3 CareFusion(BD) Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CareFusion(BD) Pulmonary Function Testing Systems Product Portfolio
  6. 8.1.5 CareFusion(BD) Recent Developments
  7. 8.2 Schiller
  8. 8.2.1 Schiller Company Information
  9. 8.2.2 Schiller Business Overview
  10. 8.2.3 Schiller Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Schiller Pulmonary Function Testing Systems Product Portfolio
  12. 8.2.5 Schiller Recent Developments
  13. 8.3 CHEST
  14. 8.3.1 CHEST Company Information
  15. 8.3.2 CHEST Business Overview
  16. 8.3.3 CHEST Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CHEST Pulmonary Function Testing Systems Product Portfolio
  18. 8.3.5 CHEST Recent Developments
  19. 8.4 COSMED
  20. 8.4.1 COSMED Company Information
  21. 8.4.2 COSMED Business Overview
  22. 8.4.3 COSMED Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 COSMED Pulmonary Function Testing Systems Product Portfolio
  24. 8.4.5 COSMED Recent Developments
  25. 8.5 nSpire Health
  26. 8.5.1 nSpire Health Company Information
  27. 8.5.2 nSpire Health Business Overview
  28. 8.5.3 nSpire Health Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 nSpire Health Pulmonary Function Testing Systems Product Portfolio
  30. 8.5.5 nSpire Health Recent Developments
  31. 8.6 NDD
  32. 8.6.1 NDD Company Information
  33. 8.6.2 NDD Business Overview
  34. 8.6.3 NDD Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 NDD Pulmonary Function Testing Systems Product Portfolio
  36. 8.6.5 NDD Recent Developments
  37. 8.7 MGC Diagnostics
  38. 8.7.1 MGC Diagnostics Company Information
  39. 8.7.2 MGC Diagnostics Business Overview
  40. 8.7.3 MGC Diagnostics Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 MGC Diagnostics Pulmonary Function Testing Systems Product Portfolio
  42. 8.7.5 MGC Diagnostics Recent Developments
  43. 8.8 Minato
  44. 8.8.1 Minato Company Information
  45. 8.8.2 Minato Business Overview
  46. 8.8.3 Minato Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Minato Pulmonary Function Testing Systems Product Portfolio
  48. 8.8.5 Minato Recent Developments
  49. 8.9 Ganshorn
  50. 8.9.1 Ganshorn Company Information
  51. 8.9.2 Ganshorn Business Overview
  52. 8.9.3 Ganshorn Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Ganshorn Pulmonary Function Testing Systems Product Portfolio
  54. 8.9.5 Ganshorn Recent Developments
  55. 8.10 AESRI
  56. 8.10.1 AESRI Company Information
  57. 8.10.2 AESRI Business Overview
  58. 8.10.3 AESRI Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 AESRI Pulmonary Function Testing Systems Product Portfolio
  60. 8.10.5 AESRI Recent Developments
  61. 8.11 Morgan Scientific
  62. 8.11.1 Morgan Scientific Company Information
  63. 8.11.2 Morgan Scientific Business Overview
  64. 8.11.3 Morgan Scientific Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Morgan Scientific Pulmonary Function Testing Systems Product Portfolio
  66. 8.11.5 Morgan Scientific Recent Developments
  67. 8.12 M&B
  68. 8.12.1 M&B Company Information
  69. 8.12.2 M&B Business Overview
  70. 8.12.3 M&B Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 M&B Pulmonary Function Testing Systems Product Portfolio
  72. 8.12.5 M&B Recent Developments
  73. 8.13 Sikeda
  74. 8.13.1 Sikeda Company Information
  75. 8.13.2 Sikeda Business Overview
  76. 8.13.3 Sikeda Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sikeda Pulmonary Function Testing Systems Product Portfolio
  78. 8.13.5 Sikeda Recent Developments
  79. 8.14 RSDQ
  80. 8.14.1 RSDQ Company Information
  81. 8.14.2 RSDQ Business Overview
  82. 8.14.3 RSDQ Pulmonary Function Testing Systems Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 RSDQ Pulmonary Function Testing Systems Product Portfolio
  84. 8.14.5 RSDQ Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pulmonary Function Testing Systems Value Chain Analysis
  2. 9.1.1 Pulmonary Function Testing Systems Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pulmonary Function Testing Systems Sales Mode & Process
  6. 9.2 Pulmonary Function Testing Systems Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pulmonary Function Testing Systems Distributors
  9. 9.2.3 Pulmonary Function Testing Systems Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst